Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Board restructuring

9 May 2013 07:00

RNS Number : 2953E
First Derivatives PLC
09 May 2013
 



First Derivatives plc

("First Derivatives" or the "Company")

 

Establishment of Executive Management Committee and restructuring of Board of Directors

 

First Derivatives (AIM: FDP.L, ESM: GYQ.I), a leading provider of software and consulting services to the capital markets industry, announced today that the board has recently completed a review of the Company's decision making processes and announces the creation of an Executive Management Committee and a restructuring of the Company's Board of Directors.

 

First Derivatives floated on AIM in March 2002 and has since grown revenues from £1.8 million to £46.1m in the year to February 2012. During this period the Company has expanded from a single office in Newry, Co Down, employing 26 members of staff, to a global network of 10 offices employing over 720 people.

 

The Company is well positioned for continued expansion and further growth. In anticipation of this further growth the board has created a new management structure appropriate for a rapidly growing international business.

 

The board believes that the reorganisation of directors' and management's responsibilities better reflects the operational structure of the Company and also more closely reflects the provisions of the UK Corporate Governance Code.

 

Group management responsibilities will now be conducted through the recently-created Executive Management Committee. The composition of the Executive Management Committee reflects the organisational structure and central functions of the Company and is comprised of Brian Conlon, Graham Ferguson, Adrian Toner, Kevin Cunningham, Brendan Duffy, Gerry Buggy and Tom Kozlowski.

 

First Derivatives' Board of Directors will remain responsible for the strategic development of the Company, for all matters of corporate governance and related shareholder matters.

 

The Board will comprise:

David Anderson Non-Executive Chairman

Brian Conlon Chief Executive Officer

Graham Ferguson Chief Finance Officer

Pat Brazel Non-Executive Director

Keith MacDonald Non-Executive Director

Seamus Keating Non-Executive Director

 

Therefore, with immediate effect Adrian Toner and Kevin Cunningham, will resign as directors of the Company but will remain members of the Executive Management Committee.

 

Michael O'Neill will also resign with immediate effect from the Board of Directors. Michael joined First Derivatives in 1997, soon after its formation, and was instrumental in helping build the business to its current scale and global presence from both an operational and strategic perspective. He remained an Executive Director until 2009, and has continued since then to serve as a Non-Executive Director while developing his own business interests.

 

Commenting on Michael's resignation, Chief Executive Brian Conlon said: "I would like to thank Michael for the great service he has provided to First Derivatives over the last 16 years. The Company has grown beyond all recognition and Michael's vision and drive helped transform the Company from a small consulting organisation to a listed global software and services Company with a market capitalisation of more than £100m."

 

The board has also reviewed and amended the composition of the Remuneration Committee, as a result of which Brian Conlon will stand down and the committee will now comprise Pat Brazel (Chairman), Seamus Keating and David Anderson. The Audit Committee will comprise of Keith MacDonald (Chairman), Pat Brazel and Seamus Keating.

 

Commenting on the management restructuring David Anderson, Chairman, stated: "These changes address the need for a greater degree of structure and management flexibility within the Company as First Derivatives continues to expand into a global operating business. At the same time the board believes that the new structure also addresses the need for the Company to meet its obligations towards staff, shareholders and customers through more exacting standards of strong corporate governance."

 

 

For further information please contact:

 

First Derivatives plc +44(0)28 3025 2242

Brian Conlon, Chief Executive www.firstderivatives.com

Graham Ferguson, Chief Financial Officer

 

Charles Stanley Securities

(Nominated Adviser and Broker) +44 (0)20 7149 6000

Russell Cook

Carl Holmes

 

Goodbody Corporate Finance

(ESM Adviser and Broker) +353 1 667 0420

Diane Hodgson

Linda Hickey

 

Walbrook PR +44 (0)20 7933 8780

Bob Huxford bob.huxford@walbrookpr.com

Paul Cornelius paul.cornelius@walbrookir.com

 

 

About First Derivatives

First Derivatives is a global provider of software and consulting services to the financial services industry. With over 16 years experience working with leading financial institutions, it continues to deliver technologically advanced products and services that anticipate and respond to the evolving needs of global capital markets.

 

First Derivatives currently employs over 720 people worldwide and counts many of the world's top investment banks, brokers and hedge funds as its customers. It has operations in London, New York, Stockholm, Shanghai, Singapore, Toronto, Sydney, Dublin, Newry and Hong Kong.

 

For further information please visit www.firstderivatives.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBLGDULUGBGXI
Date   Source Headline
24th Nov 20105:35 pmRNSDirector/PDMR Shareholding
24th Nov 20101:34 pmRNSHolding(s) in Company
22nd Nov 20105:19 pmRNSDirector/PDMR Shareholding
29th Oct 20108:13 amRNSIssue of Equity
27th Oct 20107:00 amRNSHalf Yearly Report
27th Oct 20107:00 amRNSHalf Yearly Report
14th Oct 20107:00 amRNSNotice of Interim Results
10th Aug 20107:00 amRNSAppointment of Non-Executive Director
6th Aug 20107:00 amRNSEnterprise Securities Market Notice
2nd Aug 20107:00 amRNSAcquisition of LakeFront Data
28th Jul 20107:00 amRNSContract Win with Singapore Exchange
13th Jul 20107:00 amRNSLicence Agreement with Algorithmics
1st Jul 20105:33 pmRNSResult of AGM
30th Jun 20104:12 pmRNSHolding(s) in Company
30th Jun 20101:52 pmRNSTotal Voting Rights
30th Jun 20107:00 amRNSEnterprise Securities Market Notice
24th Jun 20105:10 pmRNSExercise of options
14th Jun 201011:33 amRNSHolding(s) in Company
11th Jun 20102:20 pmRNSDirector/PDMR Shareholding
11th Jun 20107:00 amRNSEnterprise Securities Market Notice
9th Jun 20107:00 amRNSAppointment of President, U.S. Operations
24th May 20107:02 amRNSDelta Software Contract Wins
24th May 20107:00 amRNSFinal Results
13th May 201010:00 amRNSBoard Change
10th May 20107:00 amRNSNotice of Final Results
16th Apr 20107:00 amRNSEntry into Japanese market
1st Apr 20103:10 pmRNSTotal Voting Rights
30th Mar 20107:00 amRNSIEX Notice
24th Mar 201010:34 amRNSIssue of Equity
19th Mar 20107:00 amRNSInvestment from Invest Northern Ireland
11th Mar 20107:00 amRNSTrading Update
17th Feb 20107:00 amRNSInvestment from Invest Northern Ireland
15th Feb 20107:00 amRNSStrategic Asset Purchase for US$4.7 Million
3rd Feb 20107:00 amRNSStatement re Potential Acquisition
1st Feb 20107:00 amRNSDistribution Agreement with BrokerEdge
12th Jan 20109:52 amRNSDirector/PDMR Shareholding
31st Dec 20097:00 amRNSTotal Voting Rights
14th Dec 20091:31 pmRNSExercise if Options
3rd Dec 200911:00 amRNSTotal Voting Rights
2nd Dec 200911:33 amRNSDistribution Agreement - update
2nd Dec 20097:00 amRNSDistribution Agreement with Religare Technologies
2nd Nov 20093:52 pmRNSTotal Voting Rights
26th Oct 20097:00 amRNSAcquisition of Reference Data Factory LLC
19th Oct 20097:00 amRNSInterim Results
19th Oct 20097:00 amRNSInvestment in Kx Systems
8th Oct 20097:00 amRNSNotice of Results
1st Oct 20094:04 pmRNSTotal Voting Rights
7th Sep 200910:00 amRNSTrading Statement
4th Sep 20097:00 amRNSIEX Notice
1st Sep 20095:17 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.